The results of research headed by a team in the lab of Michael Sigal, MD, at the Max Delbrück Center and Charité—Universitätsmedizin Berlin, have shed new light on the role of the p53 tumor suppressor ...

Increased DNA damage and slower repairing capacity in the p53 gene from blood leukocytes after HDM correlate with improved outcome of patients with MM who undergo ABSCT. These results suggest that ...

Researchers have elucidated the role of the p53 gene in ulcerative colitis. The study suggests a potential new drug target to stop disease progression to cancer. Researchers in the lab of Michael ...

LONDON, GREATER LONDON, UNITED KINGDOM, September 10, 2025 / EINPresswire.com / -- What Is The Cellular Tumor Antigen p53 Market Size And Growth?

A new study from Karolinska Institutet, published in Nature Communications, reveals that cyclin-dependent kinases (CDK) ...

Autologous T-Cell Therapies in Solid Tumor Malignancies: Current Landscape and Future Opportunities Histology-agnostic therapies: by focusing on common mutations across various cancers, this approach ...

In a twist worthy of molecular drama, scientists at Karolinska Institutet have uncovered a surprising new role for a ...

Researchers at Moffitt Cancer Center have created the first genetically engineered model of lung cancer in naked mole rats, a ...

PMV Pharmaceuticals ( ($PMVP) ) has provided an update. On September 10, 2025, PMV Pharmaceuticals announced interim data from their Phase 2 ...

New data shows Telomir-1 fully reverses STAT1 gene silencing by DNA methylation – a key immune regulator suppressed in cancer – delivering stronger epigenetic effects than Paclitaxel or Rapamycin in ...